Ultragenyx Pharmaceutical (RARE) to Release Quarterly Earnings on Thursday

Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) will issue its quarterly earnings data after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of ($1.73) per share for the quarter. Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) last announced its quarterly earnings data on Thursday, February 15th. The biopharmaceutical company […]

Related Keywords

United States ,Japan ,Canada ,America ,Matthewk Fust , ,Cantor Fitzgerald ,Royal Bank ,Ultragenyx Pharmaceutical Inc ,Canaccord Genuity Group ,Nasdaq ,Ultragenyx Pharmaceutical Company Profile ,Jpmorgan Chase Co ,Ultragenyx Pharmaceutical ,Get Free Report ,John Richard Pinion ,Director Matthew ,Pharmaceutical Inc ,North America ,Latin America ,Ultragenyx Pharmaceutical Daily ,Nasdaq Rare ,Rare ,Medical ,Earnings ,